Who are the top shareholders of the Valiant Organics?

The top shareholders of Valiant Organics include promoter Jaya Chandrakant Gogri with 8.25% and public shareholder Nikhil Parimal Desai with 9.17%. Individual investors hold 37.41%, while 17 foreign institutional investors hold a combined 0.37%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Valiant Organics include Jaya Chandrakant Gogri, who is the promoter with the highest holding at 8.25%. Additionally, the highest public shareholder is Nikhil Parimal Desai, holding 9.17%. Individual investors collectively hold a significant portion of the company at 37.41%. There are also 17 foreign institutional investors (FIIs) that hold a combined 0.37% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

how big is Valiant Organics?

As of Jun 06, Valiant Organics Ltd has a market capitalization of 1,210.64 Cr, with net sales of 718.77 Cr and a net profit of -3.74 Cr for the latest four quarters. Shareholder's Funds are 729.29 Cr and Total Assets are 1,247.96 Cr as of Mar'24.

Market Cap: As of Jun 06, Valiant Organics Ltd has a market capitalization of 1,210.64 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Valiant Organics reported net sales of 718.77 Cr and a net profit of -3.74 Cr. This data is on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: The balance sheet data is also on a Consolidated basis for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 729.29 Cr, while Total Assets amount to 1,247.96 Cr.

What is the bonus history of the Valiant Organics?

Valiant Organics issued a 1:1 bonus share on December 24, 2020, with a record date of December 28, 2020, effectively doubling shareholders' holdings.

Valiant Organics has a bonus history that includes a notable 1:1 bonus issue announced with an ex-date of December 24, 2020. The record date for this bonus was December 28, 2020. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time. If you have any more questions about Valiant Organics or need further details, feel free to ask!

Has Valiant Organics declared dividend?

Valiant Organics Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of February 10, 2023. However, the company has shown significant variability in total returns, with negative returns in longer periods and a dividend yield of 0%.

Valiant Organics Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 10 Feb 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 27.24%, the dividend return was 0%, resulting in a total return of 27.24%.<BR><BR>Over the past year, the price return was 10.57%, with a dividend return of 0%, leading to a total return of 10.57%.<BR><BR>In the 2-year period, the price return was -29.27%, the dividend return was 0%, resulting in a total return of -29.27%.<BR><BR>For the 3-year period, the price return was -34.02%, with a dividend return of 0.86%, culminating in a total return of -33.16%.<BR><BR>In the 4-year period, the price return was -72.23%, the dividend return was 0.30%, resulting in a total return of -71.93%.<BR><BR>Over the last 5 years, the price return was -35.84%, with a dividend return of 1.14%, leading to a total return of -34.7%.<BR><BR>Overall, while Valiant Organics has declared a dividend, the total returns over various periods show significant variability, with some periods reflecting negative returns, particularly in the longer term. The absence of a consistent dividend yield further indicates challenges in maintaining shareholder value.

Who are the peers of the Valiant Organics?

Valiant Organics' peers include Jyoti Resins, Platinum Industries, Oriental Aromatics, Fairchem Organic, Amal, Indo Amines, Indokem, Nitta Gelatin, and Jayant Agro Org. In terms of management risk, growth ratings, and capital structure, Valiant Organics shows average performance, with a 1-year return of 5.17%, significantly lower than Indokem's 278.31%.

Peers: The peers of Valiant Organics are Jyoti Resins, Platinum Industr, Oriental Aromat., Fairchem Organic, Amal, Indo Amines, Indokem, Nitta Gelatin, and Jayant Agro Org.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jyoti Resins, Platinum Industr, Amal, Nitta Gelatin, and Jayant Agro Org., while Average management risk is found at Oriental Aromat., Fairchem Organic, Indo Amines, and Valiant Organics, and Below Average management risk is noted at Indokem. Growth ratings show Excellent growth at Jyoti Resins and Amal, Good growth at Indo Amines and Jayant Agro Org., Average growth at Platinum Industr and Nitta Gelatin, Below Average growth at Oriental Aromat. and Fairchem Organic, and Valiant Organics shows Below Average growth. Capital Structure is Excellent at Platinum Industr and Fairchem Organic, Good at Valiant Organics and Jayant Agro Org., Average at Amal, Below Average at Indo Amines, and Indokem, and Good at Nitta Gelatin.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indokem at 278.31%, while Fairchem Organic has the lowest at -29.77%. Valiant Organics has a 1-year return of 5.17%, which is higher than Fairchem Organic but significantly lower than Indokem. Additionally, Fairchem Organic and Indokem have negative six-month returns.

Who are in the management team of Valiant Organics?

As of March 2022, the management team of Valiant Organics includes Chairman Navin Chapshi Shah, Managing Director Arvind Chheda, and several executive and independent directors, totaling twelve key members who guide the company's governance and strategy.

As of March 2022, the management team of Valiant Organics includes the following individuals:<BR><BR>1. Navin Chapshi Shah - Chairman & Independent Director<BR>2. Arvind Chheda - Executive Director / Managing Director / Chief Financial Officer / Promoter<BR>3. Mahek Manoj Chheda - Executive Director & Wholetime Director<BR>4. Nemin Mahesh Savadia - Executive Director<BR>5. Sathiababu Krishnan Kallada - Non-Executive & Non-Independent Director<BR>6. Siddharth D. Shah - Executive Director<BR>7. Vishnu Sawant - Executive Director & Wholetime Director<BR>8. Kiritkumar Haribhai Desai - Non-Executive & Non-Independent Director<BR>9. Santosh S. Vora - Non-Executive Director<BR>10. Mulesh Manilal Savla - Independent Non-Executive Director<BR>11. Sonal A Vira - Independent Director<BR>12. Sudhirprakash Baburao Sawant - Independent Director<BR><BR>This diverse team encompasses various roles, including executive, independent, and non-executive positions, contributing to the governance and strategic direction of the company.

What does Valiant Organics do?

Valiant Organics Ltd is a specialty chemical manufacturer in the Agro Intermediate and Pharma sectors, with a market cap of INR 1,148 Cr. As of March 2025, it reported net sales of 2,038 Cr and a net profit of 42 Cr.

Overview: <BR>Valiant Organics Ltd is a specialty chemical manufacturer operating in the Agro Intermediate and Pharma sectors, categorized as a Small Cap company.<BR><BR>History: <BR>Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' in 2005. It transitioned to a Public Limited Company in 2015. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 2,038 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 42 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,148 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.33 <BR>Return on Equity: -0.52% <BR>Price to Book: 1.56<BR><BR>Contact Details: <BR>Address: 109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080 <BR>Tel: 91-22-25913767/3766/67976640/5 <BR>Email: investor@valiantorganics.com <BR>Website: http://www.valiantorganics.com

Are Valiant Organics latest results good or bad?

Valiant Organics reported strong financial results for the quarter ending June 2025, with a Profit Before Tax of Rs 10.03 crore (up 442.16% year-on-year) and net sales of Rs 204.41 crore (up 21.73%). Despite rising interest costs, the overall performance indicates significant growth and improved profitability.

Valiant Organics has reported very strong financial results for the quarter ending June 2025, indicating a positive performance overall. The company achieved a Profit Before Tax (PBT) of Rs 10.03 crore, which is a remarkable increase of 442.16% year-on-year. Profit After Tax (PAT) also saw an impressive surge to Rs 8.20 crore, reflecting a growth of 1,422.6%.<BR><BR>Net sales reached Rs 204.41 crore, marking a five-quarter high with a year-on-year growth of 21.73%. Additionally, the Operating Profit (PBDIT) stood at Rs 24.83 crore, the highest in the last five quarters, resulting in an operating profit margin of 12.15%. Earnings per Share (EPS) improved to Rs 2.93, signaling enhanced profitability for shareholders.<BR><BR>However, it’s worth noting that the company faced rising interest costs, with quarterly interest expenses increasing by 29.03% quarter-on-quarter to Rs 6.00 crore, which suggests higher borrowings. Despite this challenge, the overall financial trajectory for Valiant Organics this quarter is very positive, showcasing significant growth across key metrics.

When is the next results date for Valiant Organics?

Valiant Organics will declare its results on 13 November 2025.

Valiant Organics will declare its results on 13 November 2025.

How has been the historical performance of Valiant Organics?

Valiant Organics has faced significant fluctuations in financial performance, with net sales declining from 1,051.80 Cr in March 2023 to 718.76 Cr in March 2025, while profitability metrics have also decreased, resulting in a negative profit after tax of -2.67 Cr in March 2025. Despite a slight recovery in operating profit, the overall financial environment remains challenging.

Answer:<BR>The historical performance of Valiant Organics has shown significant fluctuations over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Valiant Organics reported net sales of 718.76 Cr in March 2025, a slight decline from 723.06 Cr in March 2024 and a notable decrease from 1,051.80 Cr in March 2023. The total operating income mirrored this trend, falling to 718.76 Cr in March 2025 from 723.06 Cr in the previous year and down from 1,051.80 Cr in March 2023. The raw material costs also decreased to 440.07 Cr in March 2025 from 483.40 Cr in March 2024, contributing to a total expenditure of 665.09 Cr in March 2025, which was lower than 684.81 Cr in March 2024. Operating profit (PBDIT) rose to 62.31 Cr in March 2025 from 47.55 Cr in March 2024, but this was significantly lower than the 172.26 Cr reported in March 2023. The profit before tax showed a recovery to 2.91 Cr in March 2025 from a loss of 7.13 Cr in March 2024, yet it was down from 137.18 Cr in March 2023. The profit after tax remained negative at -2.67 Cr in March 2025, although it improved from -6.84 Cr in March 2024. The consolidated net profit also reflected this trend, standing at -3.74 Cr in March 2025 compared to -8.39 Cr in March 2024 and a profit of 88.12 Cr in March 2023. Total assets decreased to 1,182.93 Cr in March 2025 from 1,247.96 Cr in March 2024, while total liabilities also fell to 1,182.93 Cr from 1,247.96 Cr. Cash flow from operating activities was 56.00 Cr in March 2025, down from 84.00 Cr in March 2024, indicating a decline in cash generation capabilities. Overall, Valiant Organics has experienced a challenging financial environment with fluctuating sales and profitability metrics over the past few years.

Should I buy, sell or hold Valiant Organics?

Is Valiant Organics overvalued or undervalued?

As of November 27, 2025, Valiant Organics is considered overvalued with a PE ratio of 30.94 and an EV to EBITDA of 11.73, especially when compared to peers like Cipla and Sun Pharma, and has underperformed the Sensex with a year-to-date return of -14.77%.

As of 27 November 2025, Valiant Organics has moved from a very attractive to an attractive valuation grade. The company appears to be overvalued based on its current metrics. The PE ratio stands at 30.94, while the EV to EBITDA is 11.73 and the PEG ratio is notably low at 0.18, indicating potential overvaluation compared to growth expectations.<BR><BR>In comparison to its peers, Valiant Organics' valuation seems less favorable. For instance, Sun Pharma has a PE ratio of 37.62 and an EV to EBITDA of 24.87, categorizing it as expensive, while Cipla, also rated attractive, has a PE of 22.67 and an EV to EBITDA of 16.04. Furthermore, Valiant's recent stock performance has lagged significantly behind the Sensex, with a year-to-date return of -14.77% compared to the Sensex's 9.70%, reinforcing the notion that it may be overvalued in the current market context.

Is Valiant Organics technically bullish or bearish?

As of December 1, 2025, the trend is mildly bearish due to bearish momentum from the weekly MACD and Bollinger Bands, although monthly indicators suggest potential for recovery.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish momentum. The daily moving averages also reflect a bearish outlook. However, the monthly MACD and KST show mildly bullish signals, suggesting some potential for recovery over a longer time frame. Overall, the lack of strong bullish signals and the prevailing bearish indicators indicate a cautious approach is warranted.

Why is Valiant Organics falling/rising?

As of 14-Dec, Valiant Organics Ltd's stock price is slightly rising at 273.35, despite a year-to-date drop of 10.38% and a 57.12% decline over three years. The current increase may reflect sector trends, but decreased investor participation could limit future gains.

As of 14-Dec, Valiant Organics Ltd's stock price is rising slightly, with a current price of 273.35, reflecting a change of 0.8 (0.29%) upward. This increase comes despite a broader context of declining performance over longer periods, such as a year-to-date drop of 10.38% and a significant 57.12% decline over the past three years. <BR><BR>Today's performance is noted as being in line with the sector, which may suggest that the stock is responding positively to sector-wide trends. However, it is important to highlight that the stock is currently above its 5-day and 20-day moving averages, indicating a short-term upward trend. Conversely, it remains below its longer-term moving averages (50-day, 100-day, and 200-day), which could indicate potential resistance to sustained upward movement.<BR><BR>Additionally, there is a concerning trend in investor participation, as the delivery volume has decreased significantly by 71.57% compared to the 5-day average. This decline in participation may suggest that while the stock is experiencing a slight rise today, there is a lack of strong investor interest, which could limit future price increases. Overall, the stock's current rise appears to be a minor fluctuation amidst a backdrop of longer-term declines and reduced investor engagement.

Which are the latest news on Valiant Organics?